BIOCON closes
at ₹ 608.2 with a Gain of +0.1% on 06-June-
-2018 with formation of a small Green Candle
on Daily Price Chart.
Valuations
: BIOCON’s Biopharma is key driver for growth which is expected to
grow at a rate of 36% CGAR from 2018-2020 & EPS from 5.3 to 36.4 . It is
now Trading at 11.9X of its EPV ( March 2018 earnings ) Its 10 years avg. long
term EPV comes at 7.3, which translates its effective price at ₹ 373.00. It has Net Cash / Share of Rs.114.90
Disclaimer
: We are / may going to take exposure shortly.
Join Us at WhatsApp: 1. https://chat.whatsapp.com/6RaxJrOD5UzFi1uw0hgBCo ( Free )
2. https://chat.whatsapp.com/8sR3MYOXvSFIIa56Tc7Ush (Premium )
$$$ We are active at Twitter # NIFTYNEXT1
2. https://chat.whatsapp.com/8sR3MYOXvSFIIa56Tc7Ush (Premium )
$$$ We are active at Twitter # NIFTYNEXT1